GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Feasiblity Analysis of a Clinical Electroporation System

$96,175
Ichor Medical Systems, Inc. · R44 · FY2001 · CA

Core B: Preclinical Therapeutics Core

$96,117
Cyril Henri Benes · University Of Tx Md Anderson Can Ctr · P01 · FY2017 · CA

A Phase I Study of Mistletoe Extract on PK, PD, and Safety of Gemcitabine in CA

$96,000
Patrick J Mansky · National Center For Complementary & Integrative Health · Z01 · FY2008 · AT

Outreach Core

$95,860
Sandra G Suther · Florida Agricultural And Mechanical Univ · U54 · FY2020 · CA

Administrative Core

$95,826
Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2022 · CA

Project 2: Enhancing Efficacy of Gemcitabine Nanoparticles in Pancreatic PDX Models

$95,816
Bo Han · University Of Southern California · U54 · FY2020 · CA

Identifying Metabolic Vulnerabilities in Pancreatic Cancer

$95,669
Douglas Biancur · New York University School Of Medicine · K00 · FY2022 · CA

Developmental Research Program

$95,439
Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2018 · CA

Eastern Cooperative Oncology Group

$95,412
Michael B Atkins · Beth Israel Deaconess Medical Center · U10 · FY2011 · CA

Eastern Cooperative Oncology Group

$95,411
Glenn J Bubley · Beth Israel Deaconess Medical Center · U10 · FY2012 · CA

Defining the barriers to immune surveillance in solid tumors

$95,308
Samarth Hegde · Icahn School Of Medicine At Mount Sinai · K00 · FY2022 · CA

Targets, Modulators and Delivery Program

$95,177
Sarah A Holstein · University Of Nebraska Medical Center · P30 · FY2024 · CA

Targets, Modulators and Delivery Program

$95,175
Sarah A Holstein · University Of Nebraska Medical Center · P30 · FY2023 · CA

Targets, Modulators and Delivery Program

$95,175
Sarah A Holstein · University Of Nebraska Medical Center · P30 · FY2022 · CA

Multi-Center Study of Pancreatic Cancer Etiology

$95,118
Margaret T Mandelson · Kaiser Foundation Health Plan Of Washington · R01 · FY2009 · CA

Musashi-mediated control of pancreatic cancer growth and progression

$95,085
Tannishtha Reya · University Of California, San Diego · R01 · FY2019 · CA

Novel Determinants and Measures of Smokeless Tobacco Use

$95,060
Dorothy K Hatsukami · University Of Minnesota · R01 · FY2014 · CA

Keystone Symposia on Cellular and Molecular Basis of Metabolic Disorders Series

$95,000
James Wavell Aiken · Keystone Symposia · R13 · FY2012 · DK

Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology

$94,996
Timothy Patrick Spicer · Scripps Florida · R33 · FY2019 · CA

Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology

$94,996
Timothy Patrick Spicer · Scripps Florida · R33 · FY2018 · CA

TGFBeta1 signaling and radiation response in pancreas CA

$94,974
Geisinger Medical Center · R01 · FY2004 · CA

Validation of MRI Microvascular Biomarkers in Pancreatic Cancer with Magnetic Nanoparticles

$94,951
Alexander Savio Ramos Guimaraes · Oregon Health & Science University · K08 · FY2014 · EB

Multi-Parameter Monitoring of Breast Cancer Progression and Therapeutic Response

$94,933
Anna Moore · Massachusetts General Hospital · R01 · FY2010 · CA

Targets, Modulators and Delivery Program

$94,916
Sarah A Holstein · University Of Nebraska Medical Center · P30 · FY2021 · CA

Are shared controls useful in genome-wide association studies for cancer genetic

$94,800
Robert J. Klein · Sloan-Kettering Inst Can Research · R03 · FY2010 · CA